<body> <div id="shinytab4" class="section level2">&#13;
<h2>Further Information</h2>&#13;
<ul><li>For this app, the underlying function running the simulation is called <code>simulate_pkpdmodels.R</code>. You can call these functions directly, without going through the shiny app. Type <code>?simulate_pkpdmodel</code> into the R console for more information on how to use the functions directly.<br/></li>&#13;
<li>If you want to learn a bit more about these kinds of models, see e.g. <span class="citation">(Powers et al. 2003; Talal et al. 2006; Handel, Margolis, and Levin 2009; Canini et al. 2014)</span>.</li>&#13;
</ul><div id="references" class="section level3 unnumbered">&#13;
<h3>References</h3>&#13;
<div id="refs" class="references">&#13;
<div id="ref-canini14a">&#13;
<p>Canini, Laetitia, Jessica M Conway, Alan S Perelson, and Fabrice Carrat. 2014. “Impact of Different Oseltamivir Regimens on Treating Influenza a Virus Infection and Resistance Emergence: Insights from a Modelling Study.” <em>PLoS Computational Biology</em> 10 (4): e1003568. doi:<a href="https://doi.org/10.1371/journal.pcbi.1003568">10.1371/journal.pcbi.1003568</a>.</p>&#13;
</div>&#13;
<div id="ref-handel09b">&#13;
<p>Handel, Andreas, Elisa Margolis, and Bruce R Levin. 2009. “Exploring the Role of the Immune Response in Preventing Antibiotic Resistance.” <em>Journal of Theoretical Biology</em> 256 (4): 655–62. doi:<a href="https://doi.org/10.1016/j.jtbi.2008.10.025">10.1016/j.jtbi.2008.10.025</a>.</p>&#13;
</div>&#13;
<div id="ref-powers03">&#13;
<p>Powers, Kimberly A, Narendra M Dixit, Ruy M Ribeiro, Preeti Golia, Andrew H Talal, and Alan S Perelson. 2003. “Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b.” <em>Semin Liver Dis</em> 23 Suppl 1: 13–18. doi:<a href="https://doi.org/10.1055/s-2003-41630">10.1055/s-2003-41630</a>.</p>&#13;
</div>&#13;
<div id="ref-talal06">&#13;
<p>Talal, Andrew H, Ruy M Ribeiro, Kimberly A Powers, Michael Grace, Constance Cullen, Musaddeq Hussain, Marianthi Markatou, and Alan S Perelson. 2006. “Pharmacodynamics of Peg-IFN Alpha Differentiate Hiv/Hcv Coinfected Sustained Virological Responders from Nonresponders.” <em>Hepatology</em> 43 (5): 943–53.</p>&#13;
</div>&#13;
</div>&#13;
</div>&#13;
</div> </body>
